SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-030110
Filing Date
2022-03-03
Accepted
2022-03-03 17:22:04
Documents
15
Period of Report
2022-03-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224554d2_8k.htm   iXBRL 8-K 31178
2 EXHIBIT 5.1 tm224554d2_ex5-1.htm EX-5.1 12483
6 GRAPHIC tm224554d2_ex5-1img001.jpg GRAPHIC 6183
7 GRAPHIC tm224554d2_ex5-1img002.jpg GRAPHIC 14573
  Complete submission text file 0001104659-22-030110.txt   248857

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abus-20220303.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abus-20220303_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abus-20220303_pre.xml EX-101.PRE 22603
9 EXTRACTED XBRL INSTANCE DOCUMENT tm224554d2_8k_htm.xml XML 3533
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 22710380
SIC: 2834 Pharmaceutical Preparations